All Stories

  1. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients in Malaysia
  2. AB0781 Malaysia Spondylarthritis Accelerated Management (SAM) Model: Expediting AxSpA patient journey from early referral, diagnosis and access to optimal care
  3. Algorithm for the referral of patients with inflammatory back pain from primary care in Malaysia
  4. POS1075 PREDICTIVE FACTORS ASSOCIATED WITH DEVELOPMENT OF PSORIATIC ARTHRITIS IN PATIENTS WITH UNDERLYING PSORIASIS
  5. Ocular surface disease in psoriatic patients in a developing country
  6. Early damage as measured by SLICC/ACR damage index is a predictor of hospitalization in systemic lupus erythematosus (SLE)
  7. Fatigue and associated factors in a multi‐ethnic cohort of rheumatoid arthritis patients
  8. SAT0597 EARLY DAMAGE AS MEASURED BY SLICC/ACR DAMAGE INDEX IS A PREDICTOR OF HOSPITALIZATION IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
  9. Personal experience and knowledge about psoriasis reduce misconceptions and discriminatory behavior toward people living with psoriasis in Malaysia
  10. Drug-related problems in patients with rheumatoid arthritis
  11. Pregnancy-associated osteoporosis: a UK case series and literature review
  12. Exploring sub-optimal response to tumour necrosis factor inhibitors in axial spondyloarthritis
  13. Conventional synthetic disease-modifying antirheumatic drug use by race/ethnicity and factors associated with initiating biologics in Malaysian patients with rheumatoid arthritis
  14. AB1341 Profile and important characteristics of rheumatological diseases managed over one year in a urban university based rheumatology clinic in kuala lumpur, malaysia
  15. Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort: reply
  16. Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort
  17. SAT0392 The Drug Survival of Anti-Tumour Necrosis Factor (TNF) Treatment in A UK Cohort of Axial Spondyloarthritis Patients
  18. Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort
  19. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement
  20. Myocardial infarction with normal coronaries: an unexpected finding in a 13-year-old girl with systemic lupus erythematosus
  21. Painless ascites and elevated CA125: initial presentation of lupus-associated protein-losing enteropathy
  22. Chronic intestinal pseudo-obstruction: a rare first manifestation of systemic lupus erythematosus